The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
Pharmaceutical Technology on MSN2d
AstraZeneca’s Fasenra to challenge GSK’s Nucala in rare vasculitis after FDA nodBefore the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...
Understanding those ingredients, will impart you the essentials of the pharmaceutical market in Egypt. GSK has understood the game of access in Egypt earlier than other companies. By buying two ...
Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief ...
Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback